Detalhe da pesquisa
1.
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
Nature
; 592(7854): 450-456, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762733
2.
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study.
Hepatology
; 76(4): 1000-1012, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313048
3.
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
Liver Int
; 43(3): 695-707, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36577703
4.
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.
J Hepatol
; 76(2): 353-363, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34648895
5.
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma.
Liver Int
; 42(11): 2538-2547, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986902
6.
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study.
Br J Cancer
; 124(2): 407-413, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33071284
7.
Systemic treatment of HCC in special populations.
J Hepatol
; 74(4): 931-943, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248171
8.
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
; 17(18): 2315-2324, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33663264
9.
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
Br J Cancer
; 120(2): 165-171, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420614
10.
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine.
J Autoimmun
; 100: 17-26, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862450
11.
Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib.
Future Oncol
; 15(21): 2449-2462, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31204849
12.
Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer.
Future Oncol
; 15(18): 2107-2112, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31161795
13.
Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND).
Future Oncol
; 15(35): 4009-4017, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31746632
14.
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study.
Lancet Oncol
; 19(5): 682-693, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29625879
15.
Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?
Ann Surg Oncol
; 25(6): 1676-1685, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29488188
16.
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases.
World J Surg
; 42(8): 2651-2659, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29423737
17.
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications.
Gastric Cancer
; 20(3): 428-437, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27530622
18.
Gauging the quality-of-life benefits of immunotherapy in hepatocellular carcinoma.
Lancet Oncol
; 22(7): 896-898, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051881
19.
Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study.
Br J Cancer
; 124(9): 1611, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531694
20.
Diagnostic accuracy of ¹¹C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma.
Eur J Nucl Med Mol Imaging
; 42(9): 1399-407, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25962590